INMUNE BIO INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
INMUNE BIO INC. (INMB) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 50.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-03-27
- INMUNE BIO INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 50.00%, a 0.00% change from fiscal 2023.
- INMUNE BIO INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was 50.00%, a 0.00% change from fiscal 2022.
- INMUNE BIO INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 50.00%, a 0.00% change from fiscal 2021.
- INMUNE BIO INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was 50.00%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2024-12-31 | 50.00% 10-K · filed 2025-03-27 |
| 2023-12-31 | 50.00% 10-K · filed 2024-03-28 |
| 2022-12-31 | 50.00% 10-K · filed 2023-03-02 |
| 2021-12-31 | 50.00% 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |